Crocs, Inc. vs Revvity Inc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while Revvity Inc trades at $115.76 (market cap $12.91B). The key difference: Revvity Inc is far larger — about 2× Crocs, Inc.'s market cap, and Revvity Inc pays a 0.24% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| CROX | RVTY | |
|---|---|---|
Market Cap | $6.31B | $12.91B |
Sector | Consumer Staples | Technology |
52-Week High | $141.19 | $117.75 |
52-Week Low | $73.39 | $82.26 |
Enterprise Value | $7.83B | $15.23B |
Dividend Yield | — | 0.24% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $114.66, up 0.37% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a 54.98% gross margin and $241.20M net income for 2025, supported by positive news including product launches and raised 2026 guidance. Analyst consensus is a buy with a $120.50 price target, indicating potential upside from current levels.
Outlook remains positive due to consistent earnings outperformance and innovation in diagnostics, but risks include high P/E valuation and competitive pressures. Investors may find opportunity in sustained margin strength and AI integration, though macroeconomic sensitivity warrants caution.
Trailing returns across standard periods
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →